UK markets close in 5 hours 25 minutes

H.U. Group Holdings, Inc. (4544.T)

Tokyo - Tokyo Delayed price. Currency in JPY
Add to watchlist
2,349.00+30.00 (+1.29%)
At close: 03:15PM JST

H.U. Group Holdings, Inc.

Shinjuku Mitsui Building
2-1-1 Nishishinjuku Shinjuku-ku
Tokyo 163-0408
Japan
81 3 5909 3335
https://www.hugp.com

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees5,295

Key executives

NameTitlePayExercisedYear born
Mr. Shigekazu TakeuchiChairman, President & Group CEO131MN/A1953
Ms. Atsuko MurakamiExecutive Officer of Accounting & Finance and CFON/AN/AN/A
Isao TadaDivision Head of Procurement DivisionN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in JPY.

Description

H.U. Group Holdings, Inc., together with its subsidiaries, operates healthcare business in Japan, the United States, Europe, and internationally. The Lab Testing and Its Related Services segment collects specimens from medical offices, clinics, and hospitals, and conducts various tests at its laboratories. The segment also provides precision of the tests, pre-trial setup work, specimen collection and transport, measuring, result reports, and data management services for support in research and development of medicine. The In Vitro Diagnostics segment is involved in the provision of cerebrospinal fluid reagent, compatible with its automated chemiluminescent enzyme immunoassay system; development of blood-based reagents, as well as biomarkers specifically for neurodegenerative diseases, such as Alzheimer's. This segment also supplies key raw materials to global in-vitro diagnostics companies through a CDMO business model; offers Lumipulse, an automated chemiluminescence enzyme immunoassay system that offers reagents; and rapid diagnostics kits that serves as a platform for testing infectious diseases such as influenza and COVID-19. The Healthcare-related Services segment provides in-house sterilization services at the central supply rooms in hospitals and external sterilization at the sterilization centers; and offers operating and endoscopy room support, medical equipment maintenance and inspection, and logistics management and transportation services. This segment also engages in the sale of medical equipment, supplies, and consumables related to central supply and operating rooms; provision of home medical care and nursing services; and rental of nursing care equipment, such as wheelchairs and nursing beds. The company was formerly known as Miraca Holdings Inc. and changed its name to H.U. Group Holdings, Inc. in July 2020. H.U. Group Holdings, Inc. was incorporated in 1950 and is headquartered in Tokyo, Japan.

Corporate governance

H.U. Group Holdings, Inc.’s ISS governance QualityScore as of 1 June 2024 is 3. The pillar scores are Audit: 1; Board: 1; Shareholder rights: 9; Compensation: 6.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.